Schwangerschafts-beratung und Epilepsie : Retrospektive Analyse bei 118 Frauen

Background. The aim of this study was to evaluate the treatment of women with epilepsy investigated prior to or during pregnancy. Patients. One hundred eighteen women (median age 28.9 years) with idiopathic (n=43), cryptogenic (n=41), or symptomatic (n=29) epilepsy and appearing for special pregnancy planning advice at a German epileptology clinic were evaluated. All patients were investigated between 2002 and 2007. Findings. Of the study patients, 69 were seen prior to pregnancy, 41 (59.4%) were on monotherapy with antiepileptic drugs (AED), and 22 (31.9%) were already on folic acid supplementation. A change in AED medication was recommended in 50 (72.5%). Ninety-three of the patients were seen during pregnancy, most often during the first tri-menon (n=44). Fifty-one (55%) were on AED monotherapy, most often with lamotrigine (n=24) or valproate (n=13). During pregnancy, seizure frequency increased in 33 women (35.5%) and decreased in 14 (15%). Conclusion. Monotherapy with AED should be established if possible, and folic acid supplementation should be started prior to pregnancy.